Validus Pharmaceuticals

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 2 drugs with upcoming expirations

Activity

Key Events

Oct 7, 2025FDALasix — LASIX ONYU

Sep 12, 2025FDABumex — ENBUMYST

Jun 24, 2025FDANorpramin — NORPRAMIN

Oct 7, 2022FDALasix — FUROSCIX

Nov 9, 2018FDANorpramin — NORPRAMIN

Oct 24, 2016TrialDB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

5 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Lasix4 patentsApr 3, 2034 Lasix12 patentsJan 2, 2040 Bumex3 patentsDec 4, 2040 LasixJan 9, 2042 BumexMay 14, 2045

Regulatory

Regulatory Timeline

19921 event

FDASep 3

Norpramin — NORPRAMIN

Application NDA014399

19972 events

FDASep 11

Anzemet — ANZEMET

Application NDA020624 (NDA)

FDASep 11

Anzemet — ANZEMET

Application NDA020623 (NDA)

20004 events

FDAMay 23

Norpramin — NORPRAMIN

Application NDA014399

FDAMay 23

Norpramin — NORPRAMIN

Application NDA014399

FDAMay 23

Norpramin — NORPRAMIN

Application NDA014399

FDAMay 23

Norpramin — NORPRAMIN

Application NDA014399

20051 event

FDAJan 12

Norpramin — NORPRAMIN

Application NDA014399

20061 event

FDAApr 11

Norpramin — NORPRAMIN

Application NDA014399

20071 event

FDAJul 30

Norpramin — NORPRAMIN

Application NDA014399

20091 event

FDAOct 26

Norpramin — NORPRAMIN

Application NDA014399

20122 events

FDANov 19

Norpramin — NORPRAMIN

Application NDA014399

FDANov 19

Norpramin — NORPRAMIN

Application NDA014399

20142 events

FDAAug 7

Norpramin — NORPRAMIN

Application NDA014399

FDAJul 2

Norpramin — NORPRAMIN

Application NDA014399

20181 event

FDANov 9

Norpramin — NORPRAMIN

Application NDA014399

20221 event

FDAOct 7

Lasix — FUROSCIX

Application NDA209988 (NDA)

20253 events

FDAOct 7

Lasix — LASIX ONYU

Application NDA217294 (NDA)

FDASep 12

Bumex — ENBUMYST

Application NDA219500 (NDA)

FDAJun 24

Norpramin — NORPRAMIN

Application NDA014399

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)